Cutera (NASDAQ:CUTR) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR) in a research note published on Saturday. The firm issued a sell rating on the medical device company’s stock.

Cutera Stock Up 2.1 %

Cutera stock opened at $0.44 on Friday. Cutera has a 52-week low of $0.28 and a 52-week high of $3.00. The firm has a market capitalization of $8.86 million, a price-to-earnings ratio of -0.07 and a beta of 1.32. The firm has a 50-day moving average price of $0.43 and a two-hundred day moving average price of $0.55.

Institutional Trading of Cutera

A hedge fund recently bought a new stake in Cutera stock. Sculptor Capital LP acquired a new position in Cutera, Inc. (NASDAQ:CUTR) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned 0.82% of Cutera as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.